Lv0
0 积分 2026-08-10 加入
A response to therapy for COPD with dupilumab
1小时前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
1小时前
已完结
Patient in her 70s with COPD and asthma improving significantly since using monoclonal antibody dupilumab
2小时前
已完结
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial
2小时前
已完结
Transforming COPD management: the role of dupilumab
2小时前
已完结
The global burden of COPD: epidemiology and effect of prevention strategies
2小时前
已完结
Opportunities and challenges of COPD tertiary prevention
2小时前
已完结
Joan B Soriano-expert on asthma, COPD, and long COVID
2小时前
已关闭
Pre-COPD: an evolving concept with practice potential
2小时前
已完结
皖公网安备34019202002308
